REGN SG&A Expense Growth
Regeneron Pharmaceuticals · SG&A Expense Growth
REGN SG&A Expense Growth
Latest reported-8.61%period ending
REGN FY SG&A Growth (YoY) (0.00% → -8.61%)
Latest values, visible window
High-resolution chart · PNG
REGN sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -8.6109% | |
| 16.3379% | |
| 20.0198% | |
| 15.9461% | |
| 35.5795% | |
| 0.3055% | |
| -13.7707% | |
| 17.8553% | |
| 12.1199% | |
| 40.4485% | |
| 66.1253% | |
| 53.4606% | |
| 58.1664% | |
| 77.3437% | |
| 79.8454% | |
| 23.1997% | |
| 7.2445% | |
| 30.3262% | |
| 46.2308% | |
| 1.8727% | |
| 48.9743% | |
| 15.4007% | |
| 17.978% | |
| 30.4465% | |
| 15.6216% | |
| 29.8281% | |
| 10.3448% | |
| 0% | |
| -1.6949% | |
| 1.7241% | |
| -31.7647% | |
| -81.6415% | |
| 66.5468% | |
| 742.4242% | |
| 94.1176% | |
| 0% |